Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?

What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance

(2012) Andrew A. Udy et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration

(2010) I. Bilgrami et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Brain Microdialysis Study of Meropenem in Two Patients with Acute Brain Injury

(2010) C. Dahyot-Fizelier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Application of Basic Pharmacokinetic Concepts to Analysis of Microdialysis Data

(2009) Claire Dahyot et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetic issues for antibiotics in the critically ill patient

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Piperacillin penetration into tissue of critically ill patients with sepsis—Bolus versus continuous administration?

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of acute kidney injury: How big is the problem?

(2008) Eric A.J. Hoste et al.   CRITICAL CARE MEDICINE